DNA methylation-based profiling is an effective asset for identification of tumors in suspected, yet immunohistochemically, unspecified neuro-oncological cases
Our findings underscore the potential of integrating DNA methylation-based profiling into diagnostic workflows, contributing to an accurate diagnosis in challenging cases.
Authors
- Peter Vajkoczy (ORCID: https://orcid.org/0000-0003-4350-392X)
- Leonille Schweizer (ORCID: https://orcid.org/0000-0002-4649-2587)
- Katharina Faust (ORCID: https://orcid.org/0000-0001-9969-0141)
- David Capper (ORCID: https://orcid.org/0000-0003-1945-497X)
- Nehad M. Ayoub (ORCID: https://orcid.org/0000-0003-2284-4370)
- Christian Uhl (ORCID: https://orcid.org/0000-0002-3106-5515)
- Josefine Radke (ORCID: https://orcid.org/0000-0001-9860-2007)
- Julia Onken (ORCID: https://orcid.org/0000-0002-2859-4395)
- Felix Ehret (ORCID: https://orcid.org/0000-0001-6177-1755)
Institutions
- Goethe University Frankfurt (DE)
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- Universitätsmedizin Greifswald (DE)
- Humboldt-Universität zu Berlin (DE)
- Düsseldorf University Hospital (DE)
- German Cancer Society (DE)
- German Centre for Cardiovascular Research (DE)
- University Hospital Frankfurt (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Frankfurt Cancer Institute (DE)
- Heinrich Heine University Düsseldorf (DE)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Brain and Spine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.bas.2025.104256
- Citations
- 1
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.63